Scophthalmus maximus (turbot)
| UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
|---|---|---|---|---|---|
| A0A8D3EAH4 | Angiotensin-converting enzyme |
|
4 | 0 |
|
| A0A8D3BCI7 | P2X purinoceptor |
|
1 | 0 |
|
| A0A2U9BFC4 | Rhodopsin |
|
2 | 0 |
|
| A0A8D3AJF3 | Fibroblast growth factor receptor |
|
8 | 0 |
|
| A0A2U9C1K4 | Rhodopsin |
|
2 | 0 |
|
| A0A6A4S2Q6 | GDNF/GAS1 domain-containing protein |
|
1 | 0 |
|
| A0A8D3ALA0 | P2X purinoceptor |
|
1 | 0 |
|
| A0A6A4SIR9 | Pannexin |
|
1 | 0 |
|
| A0A8D3CH50 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
| A0A8D3BXC2 | Calcium channel, voltage-dependent, N type, alpha 1B subunit, a |
|
1 | 0 |
|
| A0A8D3DBX9 | Phosphoinositide phospholipase C |
|
1 | 0 |
|
| A0A8D3CCW7 | Phosphoinositide phospholipase C |
|
1 | 0 |
|
| A0A8D3AUH3 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
| A0A8D3D8C3 | Proto-oncogene tyrosine-protein kinase receptor Ret |
|
1 | 0 |
|
| A0A8D3BMG4 | Voltage-dependent N-type calcium channel subunit alpha |
|
1 | 0 |
|
| A0A2U9B410 | Pannexin |
|
1 | 0 |
|
| A0A8D2ZLY7 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
| A0A8D3DQ21 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
| A0A8D3EAJ0 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
| A0A8D3CHN6 | P2X purinoceptor |
|
1 | 0 |
|
| A0A8D3E419 | Angiotensin-converting enzyme |
|
2 | 0 |
|
| A0A8D2ZXC5 | Pannexin 3 |
|
1 | 0 |
|
| A0A8D3B026 | Hyaluronidase |
|
1 | 0 |
|
| A0A8D3ECB1 | P2X purinoceptor |
|
1 | 0 |
|
| A0A8D3E343 | Voltage-dependent N-type calcium channel subunit alpha |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025